Introduction

Macrocephaly is a descriptive finding of clinical importance in paediatric practice. It is usually defined as an occipito-frontal head circumference (OFC) greater than two standard deviations above the mean for age and sex, corresponding to a value above the 97th percentile on standardised growth charts.^1,2 In everyday practice, macrocephaly is one of the most frequent reasons for referral to paediatric neurology or neurosurgery.¹ Importantly, it is not a diagnosis in itself but rather a sign that may be benign or an indicator of significant underlying pathology.^1,3

Clinicians distinguish between isolated macrocephaly and secondary or pathological macrocephaly.^1,2 Isolated macrocephaly refers to children with a large head size in the absence of other abnormalities. These children have normal neurological examinations, age-appropriate developmental milestones, and no syndromic features. A family history of large head size is often present, offering reassurance.¹

Secondary macrocephaly, on the other hand, encompasses conditions where head enlargement is one aspect of a broader disorder. This group includes hydrocephalus, intracranial haemorrhage, structural brain malformations, and genetic overgrowth syndromes.^1,3 In such cases, macrocephaly is not benign but signals a disorder requiring further investigation, intervention, or ongoing surveillance. Distinguishing between isolated and secondary causes is essential because management and prognosis differ significantly.^1,2

Macrocephaly is relatively common. Depending on the definition used, it occurs in approximately 1–2% of the paediatric population.^1,2 The main challenge lies in its heterogeneity. While many infants with isolated or familial macrocephaly develop normally, others, especially those without a clear family history, may face subtle motor, cognitive, or behavioural difficulties later in life.⁴ These uncertainties highlight the importance of developmental monitoring. Serial observation and early developmental screening allow clinicians to identify the minority of children who require intervention, while reassuring families when the condition is clearly benign.^1,4

Causes of isolated macrocephaly

Two benign forms dominate clinical practice:

• Benign familial macrocephaly: In this scenario, large head size runs in families. One or both parents typically have an OFC above average, and the child follows a similar trajectory. Imaging is normal, neurological examinations are unremarkable, and developmental outcomes are generally typical^1,2
• Benign enlargement of the subarachnoid spaces (BESS): Also called benign external hydrocephalus, BESS is characterised by increased cerebrospinal fluid in the subarachnoid spaces, particularly over the frontal lobes. It typically presents in the first year of life with rapid head growth. Imaging shows widened extra-axial spaces but otherwise normal parenchyma. Most affected children are neurologically intact, although some show transient motor or language delays that improve with age^1,3

Clinical features of isolated macrocephaly

Identification of isolated macrocephaly

Diagnosis depends on careful clinical assessment. Serial OFC measurements plotted on growth charts help identify persistent macrocephaly or abnormal growth trajectories.¹ A thorough history, including parental head size and developmental milestones, is essential. Physical and neurological examinations rule out risk factors such as seizures, abnormal tone, or regression.^1,2

Imaging is reserved for cases with concerning features, such as rapid head growth or atypical findings. In infants with open fontanelles, cranial ultrasound may be helpful; however, MRI remains the gold standard when a detailed structural assessment is essential. When growth is stable, development is normal, and no abnormalities are detected, the diagnosis of isolated macrocephaly is supported.^1,2,3

Clinical presentation

Children with isolated macrocephaly are otherwise well. The finding is often made incidentally at routine well-child visits.¹ They are typically alert, interactive, and meeting milestones. Neurological examination is normal.^{1, 2} In familial cases, a family history of large heads provides reassurance. In BESS, parents may notice rapid head growth between 6 and 18 months, though children usually remain developmentally on track, with head growth plateauing by two to three years of age.^{1, 3}

Neurodevelopmental trajectories

Cognitive outcomes

Most children with isolated macrocephaly, particularly those with benign familial macrocephaly, reach normal ranges of cognitive development and academic ability.^1,4 Large-scale reviews and cohort studies show that an isolated large head, by itself, is not a reliable predictor of intellectual disability.^2,4 That said, infants with imaging-confirmed benign enlargement of the subarachnoid spaces (BESS) or non-familial macrocephaly sometimes show a higher frequency of early developmental concerns (for example lower scores on screening tests or transient delays) compared with population expectations; many of these concerns resolve with time, but a minority demonstrate persistent, subtle weaknesses in executive function, attention, or learning that can become apparent at school age. These nuances mean doctors should not assume universal benignity, but serial developmental surveillance is crucial.^1,4

Motor development (gross and fine motor skills)

Reports consistently identify gross motor delay as the most commonly observed motor issue in infants with extra-axial CSF enlargement.^1,2 In many series, infants present with delayed sitting, crawling, or cruising; most regain motor milestones as the extra-axial fluid diminishes, typically by the second to third year.^1,4 Fine motor skills are less frequently affected, but when present, fine motor lags often accompany broader global delays rather than occurring in isolation.^3,4 Persistent, progressive motor deficits or any focal neurologic signs should prompt re-evaluation and imaging.^2,3

Language and communication

Language delays are reported in a subset of infants with benign external hydrocephalus/BESS.³ Some cohorts document transient expressive language lag in toddlerhood with catch-up development later; other studies, however, identify a small group with longer-term expressive or receptive language vulnerabilities.⁴ Because language deficits may be subtle early on but significantly affect school performance, early speech-language screening and referral for therapy when concerns arise are reasonable.^2,3

Comparison with macrocephaly linked to other conditions

When macrocephaly reflects megalencephaly (true brain overgrowth), genetic overgrowth syndromes, hydrocephalus, or an underlying structural or metabolic disorder, the neurodevelopmental picture is generally worse.^1,2,3 Megalencephaly is more often associated with intellectual disability, epilepsy, and long-term neurological impairment than benign isolated macrocephaly.^1,3 Thus, the cause of head enlargement is not the size alone; it is the strongest determinant of neurodevelopmental outcome. This clinical distinction explains why careful assessment (history, exam, imaging, and selective genetic testing) is central to prognosis.^1,2,3

Risk factors

Clinical indicators

Certain signs raise suspicion for pathological causes and necessitate urgent referral:

• Rapidly increasing OFC, particularly when crossing percentiles
• Neurological symptoms such as seizures, lethargy, or focal weakness
• Signs of raised intracranial pressure, including a bulging fontanelle or split sutures
• Developmental regression or loss of previously acquired skills
• Dysmorphic features or systemic findings suggestive of syndromic or metabolic disease

When present, these features warrant imaging and specialist evaluation. In contrast, children who are asymptomatic, developmentally normal, and have a clear family history can often be monitored with reassurance.^1,2,3

Genetic and environmental considerations

Genetic causes of macrocephaly include PTEN-related conditions, RASopathies, and mutations in the PI3K-AKT-mTOR pathway.^1,2 A family history of large heads reduces the likelihood of a syndromic cause, though it cannot exclude it entirely. Environmental factors such as prematurity, perinatal haemorrhage, and infection may also result in macrocephaly or transient CSF enlargement.^1,3 When macrocephaly is accompanied by delays, dysmorphic features, epilepsy, or unusual imaging findings, genetic testing is considered.²

When to suspect progression beyond isolated macrocephaly

Progression should be suspected when:

• New neurological signs, seizures, or regression occur
• OFC accelerates rather than stabilises
• Imaging reveals ventriculomegaly, malformations, or megalencephaly
• New systemic features, such as overgrowth or skin lesions, appear

In such cases, MRI and referrals to neurology or genetics are appropriate. Early identification ensures timely management and appropriate intervention.^1,2,3

Long-term outcomes and clinical management

Prognosis

For most children with isolated macrocephaly, the prognosis is excellent. The majority achieve normal milestones and maintain typical intelligence through adolescence. Transient delays in motor or language domains usually resolve. This contrasts with secondary macrocephaly, where long-term developmental difficulties are common.^1,2,4

Follow-up and monitoring

Despite favourable outcomes, structured follow-up remains important. Recommended practices include:

• A continued OFC measurement at health visits until head growth stabilises
• Routine developmental screening, particularly in early childhood
• Imaging is reserved for atypical cases or cases with new risk factors
• Referral to early intervention services when delays are identified, since early therapy supports better long-term outcomes.^1,2,3

Counselling for parents

Counselling families is a central aspect of management. Parents are often anxious about potential brain disease.^1,2 Clinicians should provide reassurance that most children with isolated macrocephaly do very well. At the same time, families should be informed of warning signs such as rapid growth, seizures, or regression that warrant further review.^1,3 This dual approach balances reassurance with vigilance and empowers families to participate actively in their child’s care.^1,2

FAQs

How is isolated macrocephaly distinguished from pathological forms?

Isolated macrocephaly is distinguished from other pathological forms by means of stable OFC tracking, normal development, and a family history suggest isolated macrocephaly; rapid growth, neurological signs, or dysmorphic features point to pathology.

When is neuroimaging required?

Only when red factors exist—accelerated OFC, regression, seizures, or no familial pattern. MRI is preferred; ultrasound may suffice in infants.

What are the developmental outcomes in BESS?

Usually benign with transient motor or speech delays that resolve. A minority may have subtle attention or learning issues later.

Which genes are linked to progressive macrocephaly?

Mutations in PTEN, PI3K–AKT–mTOR, and RAS–MAPK pathway, often seen with overgrowth, epilepsy, or developmental delay.

Summary

Isolated macrocephaly in children is most often benign, with favourable developmental outcomes, particularly in cases of familial macrocephaly or benign external hydrocephalus^. Most affected children grow and develop normally, although a minority may experience transient or subtle developmental issues. The core principle in management is balance: providing reassurance to families while maintaining vigilance to detect atypical cases. Regular OFC monitoring, developmental screening, and open communication with parents ensure early recognition of complications. Ultimately, an individualised, family-centred approach supported by evidence-based practice offers the best outcomes for children with isolated macrocephaly.